Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (26)
Kathleen M Frey & Tasnim Tabassum. (2019) Current structure-based methods for designing non-nucleoside reverse transcriptase inhibitors. Future Virology 14:8, pages 537-544.
Crossref
Crossref
Shalley N. KudalkarJagadish BeloorElias QuijanoKrasimir A. SpasovWon-Gil Lee, José A. Cisneros, W. Mark SaltzmanPriti KumarWilliam L. Jorgensen & Karen S. Anderson. (2017) From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection. Proceedings of the National Academy of Sciences 115:4.
Crossref
Crossref
Zhongxia Zhou, Tao Liu, Dongwei Kang, Zhipeng Huo, Gaochan Wu, Dirk Daelemans, Erik De Clercq, Christophe Pannecouque, Peng Zhan & Xinyong Liu. (2018) Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored “hydrophobic channel”. Organic & Biomolecular Chemistry 16:6, pages 1014-1028.
Crossref
Crossref
Syeda Maryam Azeem, Alecia N. Muwonge, Nehaben Thakkar, Kristina W. Lam & Kathleen M. Frey. (2018) Structure-based methods to predict mutational resistance to diarylpyrimidine non-nucleoside reverse transcriptase inhibitors. Journal of Molecular Graphics and Modelling 79, pages 133-139.
Crossref
Crossref
Shalley N. Kudalkar, Jagadish Beloor, Albert H. Chan, Won-Gil Lee, William L. Jorgensen, Priti Kumar & Karen S. Anderson. (2017) Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection. Molecular Pharmacology 91:4, pages 383-391.
Crossref
Crossref
S.E. Lazerwith, D. Siegel, R.M. McFadden, M.R. Mish & W.C. Tse. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
628
664
.
Na Ye, Haiying Chen, Eric A. Wold, Pei-Yong Shi & Jia Zhou. (2016) Therapeutic Potential of Spirooxindoles as Antiviral Agents. ACS Infectious Diseases 2:6, pages 382-392.
Crossref
Crossref
Pirapon J Ohata, Anchalee Avihingsanon, Sasiwimol Ubolyam, Opass Putcharoen, Stephen J Kerr, Alain Volnysanne, Kesdao Nanthapisal, Chavalun Ruengpayyathip, Torsak Bunupuradah, Wasana Prasitsuebsai, Sivaporn Kukanok, Tanya Do, Nadia K Landolt, Kiat Ruxrungtham & Praphan Phanuphak. (2016) Updates on HIV treatment and prevention from Asia's HIV symposium: the 18th Bangkok International Symposium on HIV Medicine. Future Virology 11:4, pages 249-252.
Crossref
Crossref
M. J. Hernández Arroyo, S. E. Cabrera Figueroa, R. Sepúlveda Correa, M. P. Valverde Merino, G. Luna Rodrigo & A. Domínguez-Gil Hurlé. (2016) Influence of the number of daily pills and doses on adherence to antiretroviral treatment: a 7-year study. Journal of Clinical Pharmacy and Therapeutics 41:1, pages 34-39.
Crossref
Crossref
Kathleen M Frey. (2015) Structure-enhanced methods in the development of non-nucleoside inhibitors targeting HIV reverse transcriptase variants. Future Microbiology 10:11, pages 1767-1772.
Crossref
Crossref
Won-Gil Lee, Kathleen M. Frey, Ricardo Gallardo-Macias, Krasimir A. Spasov, Albert H. Chan, Karen S. Anderson & William L. Jorgensen. (2015) Discovery and crystallography of bicyclic arylaminoazines as potent inhibitors of HIV-1 reverse transcriptase. Bioorganic & Medicinal Chemistry Letters 25:21, pages 4824-4827.
Crossref
Crossref
William T. Gray, Kathleen M. Frey, Sarah B. Laskey, Andrea C. Mislak, Krasimir A. Spasov, Won-Gil Lee, Mariela Bollini, Robert F. Siliciano, William L. Jorgensen & Karen S. Anderson. (2015) Potent Inhibitors Active against HIV Reverse Transcriptase with K101P, a Mutation Conferring Rilpivirine Resistance. ACS Medicinal Chemistry Letters 6:10, pages 1075-1079.
Crossref
Crossref
P.G. Clay, S. Nag, C.M. Graham & S. Narayanan. (2015) Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens. Medicine 94:42, pages e1677.
Crossref
Crossref
Kathleen M. Frey, David E. Puleo, Krasimir A. Spasov, Mariella Bollini, William L. Jorgensen & Karen S. Anderson. (2015) Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants. Journal of Medicinal Chemistry 58:6, pages 2737-2745.
Crossref
Crossref
Rujuta A Bam, Gabriel Birkus, Darius Babusis, Tomas Cihlar & Stephen R Yant. (2013)
Metabolism and Antiretroviral Activity of Tenofovir Alafenamide in CD4
+
T-Cells and Macrophages from Demographically Diverse Donors
. Antiviral Therapy 19:7, pages 669-677.
Crossref
Crossref
Stephen Weller, Shuguang Chen, Julie Borland, Paul Savina, Brian Wynne & Stephen C. Piscitelli. (2014) Bioequivalence of a Dolutegravir, Abacavir, and Lamivudine Fixed-Dose Combination Tablet and the Effect of Food. JAIDS Journal of Acquired Immune Deficiency Syndromes 66:4, pages 393-398.
Crossref
Crossref
Vikram Arya, Jeffry Florian, Kendall A. Marcus, Kellie S. Reynolds, Linda L. Lewis & Adam I. Sherwat. (2014) Does an Increase in Serum Creatinine always Reflect Renal Injury? The Case of Stribild®. The Journal of Clinical Pharmacology 54:3, pages 279-281.
Crossref
Crossref
Paweł Skwara, Monika Bociąga-Jasik, Anna Kalinowska-Nowak, Iwona Sobczyk-Krupiarz & Aleksander Garlicki. (2014) Adherence to single-tablet versus multiple-tablet regimens in the treatment of HIV infection—A questionnaire-based survey on patients satisfaction. HIV & AIDS Review 13:3, pages 95-99.
Crossref
Crossref
JoEllyn M. McMillan & Howard E. Gendelman. 2014. Humanized Mice for HIV Research. Humanized Mice for HIV Research
381
396
.
JoEllyn M. McMillan & Howard E. Gendelman. 2014. Neuroinflammation and Neurodegeneration. Neuroinflammation and Neurodegeneration
529
546
.
Won-Gil Lee, Ricardo Gallardo-Macias, Kathleen M. Frey, Krasimir A. Spasov, Mariela Bollini, Karen S. Anderson & William L. Jorgensen. (2013) Picomolar Inhibitors of HIV Reverse Transcriptase Featuring Bicyclic Replacement of a Cyanovinylphenyl Group. Journal of the American Chemical Society 135:44, pages 16705-16713.
Crossref
Crossref
Benoit Chauvin, Sylvain Drouot, Aurélie Barrail-Tran & Anne-Marie Taburet. (2013) Drug–Drug Interactions Between HMG-CoA Reductase Inhibitors (Statins) and Antiviral Protease Inhibitors. Clinical Pharmacokinetics 52:10, pages 815-831.
Crossref
Crossref
Mariela Bollini, José A. Cisneros, Krasimir A. Spasov, Karen S. Anderson & William L. Jorgensen. (2013) Optimization of diarylazines as anti-HIV agents with dramatically enhanced solubility. Bioorganic & Medicinal Chemistry Letters 23:18, pages 5213-5216.
Crossref
Crossref
Ya-Qiu Long, Shao-Xu Huang, Zahrah Zawahir, Zhong-Liang Xu, Huiyuan Li, Tino W. Sanchez, Ying Zhi, Stephanie De Houwer, Frauke Christ, Zeger Debyser & Nouri Neamati. (2013) Design of Cell-Permeable Stapled Peptides as HIV-1 Integrase Inhibitors. Journal of Medicinal Chemistry 56:13, pages 5601-5612.
Crossref
Crossref
Nathalie Goudreau, Oliver Hucke, Anne-Marie Faucher, Chantal Grand-Maître, Olivier Lepage, Pierre R. Bonneau, Stephen W. Mason & Steve Titolo. (2013) Discovery and Structural Characterization of a New Inhibitor Series of HIV-1 Nucleocapsid Function: NMR Solution Structure Determination of a Ternary Complex Involving a 2:1 Inhibitor/NC Stoichiometry. Journal of Molecular Biology 425:11, pages 1982-1998.
Crossref
Crossref
Nathalie Goudreau, René Coulombe, Anne-Marie Faucher, Chantal Grand-Maître, Jean-Eric Lacoste, Christopher T. Lemke, Eric Malenfant, Yves Bousquet, Lee Fader, Bruno Simoneau, Jean-François Mercier, Steve Titolo & Stephen W. Mason. (2013)
Monitoring Binding of HIV-1 Capsid Assembly Inhibitors Using
19
F Ligand-and
15
N Protein-Based NMR and X-ray Crystallography: Early Hit Validation of a Benzodiazepine Series
. ChemMedChem 8:3, pages 405-414.
Crossref
Crossref